Journals / Tüberküloz ve Toraks / 2013 / Cilt: 61 - Sayı: 3

The evaluation of asthma and COPD awareness in Turkey (GARD Turkey Project-National Control Program of Chronic Airway Diseases)

Türkiye'de astım ve KOAH farkındalığının değerlendirilmesi (GARD Türkiye Projesi-Kronik Hava Yolları Hastalıkları Ulusal Kontrol Programı)

Pages
175–182
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Since these disorders are important causes of morbidity and mortality and have high impact on work and economic loss, it is important to increase knowledge among public.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Although chronic respiratory disorders are important causes of morbidity and mortality, health care workers, patients and caretakers are not well informed about these disorders.
📊
Key Findings & Data:This study was designed and performed as a Global Alliance Against Respiratory Disorders (GARD) project.Materials and Methods: People greater than 15 years of age who lived in cities with a population of 200 or greater were eligible for the study.
💡
Conclusion & Impact:Since these disorders are important causes of morbidity and mortality and have high impact on work and economic loss, it is important to increase knowledge among public.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Although chronic respiratory disorders are important causes of morbidity and mortality, health care workers, patients and caretakers are not well informed about these disorders. Therefore these problems are underdiagnosed and undertreated; also preventive measures are not widely taken. Our aim was to evaluate the knowledge of asthma and chronic obstructive pulmonary disease (COPD) in Turkey. This study was designed and performed as a Global Alliance Against Respiratory Disorders (GARD) project.Materials and Methods: People greater than 15 years of age who lived in cities with a population of 200 or greater were eligible for the study. A questionnaire including demographic data and questions regarding asthma and COPD was used for the evalution of the participants.Results: 12.000 people were selected (6000 in rural and 6000 in urban areas); 8527 people were reached. 8342 people who completed the questionnaire were included to the study. There were 4182 (50.1%) female and 4160 (%49.9) male subjects. 49.6% of the subjcets knew that COPD is a lung disease, 51.1% indicated that smoking is the most important risk factor for COPD and 48% identified quitting smoking as the most important preventive measure. Every other person had baseline knowledge on COPD. However only 25.2% knew that there are treatment options for COPD. 80% of subjects said astma can be seen in all age groups. 51.1% knew asthma is a genetic disease and 58% said it is not an infectious disease. However when whether asthma medications caused drug dependency only 27% answered as "No" while 55.2% said "They do not know".Conclusion: Awareness of COPD and asthma seem to be infsufficient among Turkish people. Since these disorders are important causes of morbidity and mortality and have high impact on work and economic loss, it is important to increase knowledge among public.

Özet

Giriş: Önemli mortalite ve morbidite nedeni olan kronik hava yolu hastalıkları gerek sağlık çalışanları gerekse hasta ve yakınları tarafından yeterince bilinmemektedir. Bu nedenle de yeterince teşhis ve tedavi edilememekte ve koruyucu önlemler uygulanamamaktadır. Çalışmamızın amacı "Kronik Hava Yolu Hastalıklarını Önleme Kontrol Programı" çerçevesinde toplumumuzda astım ve kronik obstrüktif akciğer hastalığı (KOAH) farkındalığıyla ilgili bilgilerin değerlendirilmesidir.Materyal ve Metod: Türkiye'de, nüfusu 200'den büyük kentsel ve kırsal yerleşim yerlerinde ikamet eden, 15 yaş üstü erkek ve kadınlar çalışmaya alındı. Katılımcılara astım ve KOAH ile ilgili sorular içeren anket uygulandı.Bulgular: Ülke genelinde, 6000 kent ve 6000 kırsal yerleşim merkezinde olmak üzere, toplam 12.000 kişiye gidilmiş olup, 8527 kişiye ulaşıldı. Çalışmaya anketi başarıyla tamamlayan 4182 (%50.1)'si kadın, 4160 (%49.9)'ı erkek toplam 8342 kişi dahil edildi. KOAH'ın akciğerlerle ilgili bir hastalık olduğu (%49.6), gelişiminde en önemli etkenin sigara olduğu (%51.1) ve korunma ve tedavide ilk seçeneğin sigaranın bırakılması olduğu (%48) yaklaşık her iki kişiden biri tarafından bilinmekteydi. Ancak KOAH'ın tedavi edilebilir bir hastalık olduğu toplumun %25.2'sinde bilinmekteydi. Astımın tüm yaş gruplarında görülebildiği (%80) iyi bilinmekle birlikte astımın kalıtsal bir hastalık olabileceği (%51.1) ve bulaşıcı olmadığı (%58) ortalama her iki kişiden birinde bilinmekteydi. Bununla birlikte astım ilaçlarının bağımlılık yapıp yapmadığı konusunda popülasyonun %55.2'si fikri olmadığını belirtirken, katılımcıların %27'si ilaçların bağımlılık yapmadığını belirtti.Sonuç: Astım ve KOAH ülkemizde yeterli ölçüde bilinmemektedir. Önemli mortalite ve morbidite nedeni olan, iş gücü ve ekonomik kayıplara yol açan bu hastalıklarla ilgili toplum bilincinin oluşması ve bilgi düzeyinin artırılması tedavi başarı oranlarının artırılması açısından önemlidir.

🔖

Cite This Article

YORGANCIOĞLU, A., ERSU, R. H., EKİNCİ, B., BİNGÖL, G. K., YARDIM, N., YILDIZ, F. (2022). The evaluation of asthma and COPD awareness in Turkey (GARD Turkey Project-National Control Program of Chronic Airway Diseases). Tüberküloz ve Toraks, Cilt: 61 - Sayı: 3, 175–182. https://ajindex.com/articles/618659

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. National Burden of Disease and Cost Effectiveness Project, Burden of Disease Final Report, Ministry of Health Refik Saydam Hygiene Center Presidency School of Public Health Ankara 2004. Health at a Glance Turkey 2007, Ministry of Health Refik Saydam Hygiene Center Presidency School of Public Health 2007. World Health Organization World Health Report 2004; Changing History. Geneva: World Health Organization, 2004.
  2. GARD Book Global Surveillance, Prevention and Control of Chronic Respiratory Diseases: A Comprehensive Approach. ISBN 978 92 4 156346 8 (NLM Classification: WF 140) © World Health Organization 2007. Action Plan of the Global Alliance Against Chronic Respiratory Diseases, 2008-2013, © World Health Organization 2008, ISBN 978 92 4 159720 3. Protection and Control Program of Chronic Airway Diseases Turkish Republic Administry Basic Health Services, Ankara: Koza Press, 2009, ISBN: 978-975-590-287-6.
  3. Yorgancıoğlu A, Türktaş H, Kalaycı O, Yardım N, Buzgan T, Kocabaş A, et al. The WHO global alliance against chronic respiratory diseases in Turkey (GARD Turkey). Tuberk Toraks 2009; 57: 439-52.
  4. Yorgancıoğlu A, Yardım N, Ergün P, Karlıkaya C, Kocabaş A, Mungan D, et al. Integration of GARD Turkey national program with other non-communicable diseases plans in Turkey. Tuberk Toraks 2010; 58: 213-28. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, update 2010.
  5. Roche N, Perez T, Neukirch F, Carré P, Terrioux P, Pouchain D, et al. The gap between the high impact and low awareness of COPD in the population. Rev Mal Respir 2009; 26: 521-9.
  6. Roche N, Perez T, Neukirch F, Carré P, Terrioux P, Pouchain D, et al. High prevalence of COPD symptoms in the general population contrasting with low awareness of the disease. Rev Mal Respir 2011; 28: 58-65.
  7. Stewart DG, Drake DF, Robertson C, Marwitz JH, Kreutzer JS, Cifu DX. Benefits of an inpatient pulmonary rehabilitation programme. Arch Phys Med Rehabil 2001; 82: 347-52.
  8. Netzer N, Werner P, Petro W, Matthys H. "Open-word" questions: an effective tool in gauging education of patients with COPD. Monaldi Ach Chest Dis 1996; 51: 74-6.
  9. White R, Walker P, Roberts S, Kalisky S, White P. Bristol COPD Knowledge Questionaire (BCKQ): testing what we teach patients about COPD. Chronic Respir Dis 2006; 3: 123-31. Miravitlles M, de la Roza C, Morera J, Montemayor T, Gobartt E, Martín A, et al. Chronic respiratory symptoms, spirom